Kemble George
Director
Sale 10b5-1
- Shares
- 350,987
- Price
- $10.23
- Value
- $3,591,580
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•27 filings
SGMT
Sagimet Biosciences Inc.
Net sales of $3.8M over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$3,792,726
0 buyers · 1 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$4,223,235
1 distinct insiders
Highlighted alerts
0
4 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get SGMT insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
SGMT overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
39
Raw transactions
Everything returned by the filing
4
Voluntary view
P/S trades after deterministic checks
35
Administrative noise
Stored, never alerted
12
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 64,051
- Price
- $7.76
- Footnotes
- 2
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $7.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Kemble George
Director
Sale 10b5-1
- Shares
- 20,206
- Price
- $9.95
- Value
- $201,147
Kemble George
Director
Sale 10b5-1
- Shares
- 18,844
- Price
- $7.46
- Value
- $140,529
Kemble George
Executive Chairman
Sale 10b5-1
- Shares
- 37,688
- Price
- $7.69
- Value
- $289,979
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Kemble George Director | Sale | 350,987 | $10.23 | $3,591,580 | |
| Aug 11, 2026 | Kemble George Director | Sale | 20,206 | $9.95 | $201,147 | |
| Jul 20, 2026 | Kemble George Director | Sale | 18,844 | $7.46 | $140,529 | |
| Nov 20, 2025 | Kemble George Executive Chairman | Sale | 37,688 | $7.69 | $289,979 |